Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 503
Ph III recruiting: 44
Growth YoY: +20.1%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 801–850 of 3,630 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04473794	Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts	recruiting	—	5,000	Johns Hopkins UniversityOTHER	1	Mar 2, 2026	clinicaltrials
NCT07443761	Patients Undergoing Pancreatic Surgery at the Antwerp University Hospital.(PANREG)	active not recruiting	—	2,000	University Hospital, AntwerpOTHER	1	Mar 2, 2026